In this study, we focused on an adhesion molecule expressed in CD34+ cells and examined whether the expression level of integrin β2 (CD18) is associated with the efficacy of cell transplantation therapy for cerebral infarction. This evidence concerns the gene ITGB2 and cerebral infarction.